{"slideshow_credits": null, "snippet": "With the sale of Par Pharmaceutical, the buyout firm will generate an eightfold return on its investment in three years.", "abstract": null, "section_name": "Business Day", "print_page": null, "document_type": "article", "byline": {"person": [{"firstname": "Robert", "role": "reported", "lastname": "CYRAN", "rank": 1, "organization": ""}], "original": "By ROBERT CYRAN"}, "web_url": "http://www.nytimes.com/2015/05/19/business/dealbook/tpgs-8-billion-drug-sale-a-rare-development.html", "lead_paragraph": "With the sale of Par Pharmaceutical, the buyout firm will generate an eightfold return on its investment in three years.", "headline": {"main": "TPG\u2019s $8 Billion Drug Sale a Rare Development", "content_kicker": "Breakingviews", "kicker": "Breakingviews"}, "_id": "555a34b038f0d803a0965b90", "word_count": "378", "multimedia": [], "pub_date": "2015-05-19T00:00:00Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"name": "subject", "value": "Mergers, Acquisitions and Divestitures", "is_major": "N", "rank": "1"}, {"name": "organizations", "value": "Endo International PLC", "is_major": "N", "rank": "2"}, {"name": "organizations", "value": "Par Pharmaceutical Cos Inc", "is_major": "N", "rank": "3"}, {"name": "organizations", "value": "TPG Capital", "is_major": "N", "rank": "4"}, {"name": "persons", "value": "Bonderman, David", "is_major": "N", "rank": "5"}, {"name": "subject", "value": "Drugs (Pharmaceuticals)", "is_major": "N", "rank": "6"}], "blog": [], "subsection_name": "DealBook", "type_of_material": "News"}